BTAI - CIK 0001720893
BioXcel Therapeutics, Inc. has filed 656 documents with the SEC between 2017 and 2026. The most frequent type is insider trade (225 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-05-01 | 2025-04-30 |
| Employee stock plan | S-8 | 2025-04-04 | - |
| Major company event | 8-K | 2025-04-03 | 2025-04-03 |
| Prospectus supplement | 424B5 | 2025-04-03 | - |
| Insider trade | 4 | 2025-04-01 | 2024-07-22 |
| Insider trade | 4 | 2025-04-01 | 2024-07-22 |
| Insider trade | 4 | 2025-04-01 | 2024-07-22 |
| Insider trade | 4 | 2025-04-01 | 2024-07-22 |
| Insider trade | 4 | 2025-04-01 | 2024-07-22 |
| Insider trade | 4 | 2025-04-01 | 2024-07-22 |
| Insider trade | 4 | 2025-04-01 | 2025-03-31 |
| Annual report | 10-K | 2025-03-28 | 2024-12-31 |
| Major company event | 8-K | 2025-03-27 | 2025-03-27 |
| Major company event | 8-K | 2025-03-21 | 2025-03-20 |
| Major company event | 8-K | 2025-03-21 | 2025-03-20 |
| Insider trade | 4 | 2025-03-17 | 2025-03-14 |
| Insider trade | 4 | 2025-03-17 | 2025-03-14 |
| Insider trade | 4 | 2025-03-17 | 2025-03-14 |
| Insider trade | 4 | 2025-03-17 | 2025-03-14 |
| Insider trade | 4 | 2025-03-04 | 2025-02-28 |
| Major company event | 8-K | 2025-03-04 | 2025-03-03 |
| Prospectus supplement | 424B5 | 2025-03-04 | - |
| Major company event | 8-K | 2025-03-03 | 2025-02-28 |
| SCHEDULE 13G | - | 2025-02-14 | - |
| Major company event | 8-K | 2025-02-06 | 2025-02-06 |
| Insider trade | 4 | 2025-02-04 | 2025-01-31 |
| Major company event | 8-K | 2025-01-29 | 2025-01-28 |
| EFFECT | - | 2025-01-17 | - |
| Insider trade | 4 | 2025-01-16 | 2025-01-15 |
| New insider ownership | 3 | 2025-01-16 | 2025-01-15 |
| Major company event | 8-K | 2025-01-16 | 2025-01-15 |
| Company correspondence | CORRESP | 2025-01-15 | - |
| SEC correspondence | UPLOAD | 2025-01-15 | - |
| Insider trade | 4 | 2025-01-10 | 2025-01-07 |
| Insider trade | 4 | 2025-01-10 | 2025-01-07 |
| Insider trade | 4 | 2025-01-10 | 2025-01-07 |
| Securities registration | S-3 | 2025-01-10 | - |
| Major company event | 8-K | 2025-01-08 | 2025-01-07 |
| Insider trade | 4 | 2025-01-03 | 2024-12-31 |
| Proxy statement | DEF 14A | 2024-12-30 | 2025-01-28 |
| SCHEDULE 13G | - | 2024-12-18 | - |
| PRE 14A | - | 2024-12-18 | 2025-01-28 |
| SCHEDULE 13G | - | 2024-12-18 | - |
| Insider trade | 4 | 2024-12-17 | 2024-12-14 |
| Insider trade | 4 | 2024-12-17 | 2024-12-14 |
| Insider trade | 4 | 2024-12-17 | 2024-12-14 |
| Insider trade | 4 | 2024-12-17 | 2024-12-14 |
| Insider trade | 4 | 2024-12-17 | 2024-12-14 |
| Insider sale notice | 144 | 2024-12-16 | - |
| Insider sale notice | 144 | 2024-12-16 | - |